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Abstract
Background: The bacillus Calmette-Guérin (BCG) vaccine protects against
tuberculosis and heterologous infections but elicits high inter-individual variation in
specific and nonspecific, or trained, immune responses. While the gut microbiome is
increasingly recognized as an important modulator of vaccine responses and
immunity in general, its potential role in BCG-induced protection is largely unknown.
Results: Stool and blood were collected from 321 healthy adults before BCG
vaccination, followed by blood sampling after 2 weeks and 3 months. Metagenomics
based on de novo genome assembly reveals 43 immunomodulatory taxa. The
nonspecific, trained immune response is detected by altered production of cytokines
IL-6, IL-1β, and TNF-α upon ex vivo blood restimulation with Staphylococcus aureus
and negatively correlates with abundance of Roseburia. The specific response,
measured by IFN-γ production upon Mycobacterium tuberculosis stimulation, is
associated positively with Ruminococcus and Eggerthella lenta. The identified
immunomodulatory taxa also have the strongest effects on circulating metabolites,
with Roseburia affecting phenylalanine metabolism. This is corroborated by
abundances of relevant enzymes, suggesting alternate phenylalanine metabolism
modules are activated in a Roseburia species-dependent manner.
Conclusions: Variability in cytokine production after BCG vaccination is associated
with the abundance of microbial genomes, which in turn affect or produce
metabolites in circulation. Roseburia is found to alter both trained immune responses
and phenylalanine metabolism, revealing microbes and microbial products that may
alter BCG-induced immunity. Together, our findings contribute to the understanding
of specific and trained immune responses after BCG vaccination.
Keywords: Nonspecific immune responses, Trained immunity, BCG, Microbiome,
Phenylalanine metabolism, Roseburia, Eggerthella lenta
Background
The bacillus Calmette-Guérin (BCG) vaccine consists of the live attenuated micro-
organism Mycobacterium bovis and partially protects against tuberculosis caused by
Mycobacterium tuberculosis in humans. Epidemiological and experimental data provide
evidence that BCG vaccination also protects against heterologous infections [1–3]. This
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nonspecific protection is at least partially explained by trained immunity, the process in
which certain infections and vaccinations result in epigenetic and metabolic rewiring of
innate immune cells that increases responsiveness upon subsequent restimulation with
unrelated pathogens [4, 5]. In monocytes and natural killer cells, trained immunity in-
duced by BCG vaccination leads to increased production of pro-inflammatory cytokines
upon restimulation with nonspecific pathogens, such as Staphylococcus aureus and
Candida albicans [6, 7]. These effects are enabled by modulation of hematopoietic
stem and progenitor cells in the bone marrow [8, 9] and last for at least 1 year [10].
However, BCG is not effective in all individuals, and host and environmental factors
underlying inter-individual variability of specific and trained immune responses to BCG
vaccination are currently incompletely understood [6, 11].
The microbiome plays an essential role in regulating immune responses [12, 13], and
numerous mechanisms have been identified through which the microbiome affects im-
mune cell functions, both locally and systemically. For example, microbiome-produced
metabolites such as short-chain fatty acids (SCFAs) directly affect myeloid cells [14],
while the attachment of segmented filamentous bacteria to the intestinal epithelium im-
proves the function of T helper 17 cells [13, 15]. Moreover, while the microbiome has
been proposed to influence the efficacy of vaccines, only a few studies have investigated
this [16, 17]. In BCG vaccine responses, two studies observed a role for gut microbiota:
mice treated with antibiotics early in life showed impaired antigen-specific IgG re-
sponses and T cell generation upon BCG vaccination as well as an increased amount of
colony forming units in the lungs upon subsequent M. tuberculosis infection [18, 19].
Furthermore, a positive association between Actinobacteria and BCG vaccine respon-
siveness in terms of T cell proliferation was observed in samples from 48 infants at 15
weeks of age [20].
Studies investigating the role of the gut microbiome on BCG-induced trained im-
mune responses, however, have not been performed to date. Here, we investigate the
effect of the gut microbiota on the induction of specific and nonspecific immune mem-
ory responses in a cohort of 321 healthy, BCG-vaccinated individuals. Through associa-
tions with the increase in cytokine production after vaccination, we identify potential
immunomodulatory species that are further supported and filtered by associations with
plasma metabolites. This approach yielded a Roseburia genome that showed consistent
associations with trained immune responses at two post-vaccination time points and
enzyme-mediated effects on phenylalanine metabolites.
Results
Microbial profile of study cohort
To study the influence of the microbiome on BCG-induced trained immunity, we vac-
cinated 321 healthy individuals of Western European background with BCG [18–75
years old, median age 23 years, 57% female, 83% body mass index (BMI) between 18.5
and 25]. Stool and blood samples were collected at baseline, prior to participants re-
ceiving the BCG vaccine. Blood was subsequently collected after 2 weeks and 3 months,
as depicted in Fig. 1A. DNA was isolated from the 321 stool samples (“Methods”), amp-
lified, and sequenced using whole genome sequencing. Peripheral blood mononuclear
cells (PBMCs) isolated from participants at each time point were subsequently
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stimulated ex vivo with S. aureus or M. tuberculosis; IL-6, IL-1β, and TNF-α were mea-
sured after 24 h and IFN-γ was measured after 7 days. Additionally, metabolites were
analyzed in plasma from peripheral blood at baseline (Koeken et al. in preparation).
Fig. 1 Study design overview and de novo assembly-based analysis of stool microbiome samples. A Study
design overview. Healthy adult volunteers (N = 321) were vaccinated with BCG at baseline, after stool and
blood samples were taken for metagenomic, metabolomic, and ex vivo cytokine production analyses.
PBMCs isolated from subjects at baseline, after 2 weeks, and after 3 months were stimulated with S. aureus
and M. tuberculosis ex vivo. B Association discovery strategy. Abundance of individual metagenomic species
pangenomes (MSPs) was compared to fold changes in cytokine expression after 2 weeks and 3 months.
MSPs significant in either modality were subsequently assessed for enrichment of associated circulating
metabolites, while metagenomic assembly was searched for enzymes explaining the differential
metabolomic potential. C Microbiome profiles were quantified as 345 MSP abundances, assembled with
MSPminer software. MSPs were matched to known taxa on the phylum (all 345), genus (315), and species
(208) levels. Barplot shows annotation levels of MSPs split in quartiles by number of genes. D Dendrogram
of samples based on Jensen-Shannon distance between relative MSP abundances reveals three clusters. The
cutoff point (dotted line) is the maximum mean difference in between-cluster and within-cluster distances
(see Figure S1). E Multi-dimensional scaling (MDS) plots of samples’ microbial abundances based on Jensen-
Shannon distance. Samples are colored by cluster (C1–C3, as in D) and cluster sizes are noted in
parentheses. The three most abundant phyla (Firmicutes, Bacteroidetes, and Actinobacteria) are highlighted.
F Per-sample relative abundances of detected phyla. Percentages in parentheses report cohort-wide
abundances. G Number of MSPs significantly associated with questionnaire variables, stratified by phylum.
Color coding as in F. The change in relative abundance of each MSP by each individual variable was
assessed by Maaslin2 generalized linear model (FDR < 0.25)
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Our approach consisted of (1) assembling all microbial species, (2) testing the microbes
for modulatory effects on cytokine responses, (3) assessing whether immunomodulatory
microbes have stronger effects on circulating metabolites compared to the other mi-
crobes, and (4) identifying which metabolites are associated with immunomodulatory
microbial species (Fig. 1B).
Reference-based profiling with MetaPhlAn 2.2 detected 202 microbial species, while
de novo genome assembly using MSPminer resulted in more than 1.7 million microbial
genes. Three hundred and forty-five core metagenomic species pangenomes (MSPs)
matched to a phylum, of which 315 (91.3%) and 208 (60.3%) matched to the genus and
species level, respectively, with more genes leading to a more precise annotation (Fig.
1C). De novo assembly was subsequently used in all downstream analyses except where
explicitly mentioned; besides retrieving all 202 initial species, this method yielded a 1.7-
fold increase in the size of the profiled metagenomic space. We hereafter use MSP to
refer to a taxonomic unit as a gene set matched to a phylum, genus, or species.
Community-level profiling using core MSP abundances yielded three distinct clusters
of samples (Fig. 1D; Additional file 1: Fig. S1A). Average cluster compositions and sam-
ple positioning in multi-dimensional scaling plots reflect abundances of the three most
common phyla (Fig. 1E). Firmicutes prevailed in cluster 1, with an average relative
abundance of 72.6%, followed by Bacteroidetes (16.64%, cluster 2) and Actinobacteria
(9.32%, cluster 3) (Fig. 1F). Cluster 1 also showed increased relative abundances of Ver-
rucomicrobia and Euryarchaeota (Additional file 1: Fig. S1B-E). The overall compos-
ition reflected that of developed, Western-type societies that tend to be dominated by
Firmicutes, while the presence of Bacteroidetes often reflects diet-driven variation [21].
This was corroborated by the species-level profiles being indistinguishable from the in-
dependent Dutch 500FG cohort of 473 healthy participants (Additional file 1: Fig. S1F-
G) [12].
All the participants in our study were asked to complete a questionnaire that in-
cluded general health-related questions. Eighteen out of 185 variables associated with
the three microbiome clusters (P < 0.05, unadjusted Cauchy test), including diet (fruit
intake), sex, smoking status, vaccination history, and gastrointestinal status-related vari-
ables (Additional file 1: Fig. S2; Additional file 2: Table S1).
Shifts in the relative abundance of individual species correlated with 25 variables
(MaAsLin2 generalized linear model, PFDR < 0.25), of which 10 correlated with more
species (Fig. 1G; Additional file 2: Table S1). In particular, vaginal yeast infection, sex,
and daily exercise associated with most microbial species (Fig. 1G). Other species-
specific variables that were missed by cluster associations included hypertension, hay
fever during youth, and antibiotic use.
Microbiome species are associated with the capacity to modulate cytokine production
after BCG vaccination
Cytokine production in the supernatant of stimulated PBMCs was measured to assess
the trained immune response (IL-6, IL-1β, TNF-α after 24-h stimulation) and the spe-
cific immune response (IFN-γ after 7-day stimulation). IL-1β and TNF-α production
upon S. aureus stimulation and IFN-γ production upon M. tuberculosis stimulation
gradually increased 2 weeks and 3 months after BCG vaccination compared to baseline
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(Fig. 2A; Additional file 1: Fig. S3A). Trained immunity (indicated by increases in TNF-
α, IL-1β, IL-6 production) as well as specific (M. tuberculosis-induced IFN-γ) and
heterologous lymphocyte-derived (S. aureus-induced IFN-γ) cytokine responses corre-
lated with each other (Fig. 2B, C). The microbiome clusters did not show a significant
divergence in any of the cytokine responses measured upon ex vivo stimulation of
PBMCs (maximum P = 0.16 for IFN-γ with S. aureus, Additional file 1: Fig. S3B),
prompting the search for a potential individual taxon or functional immunomodulatory
factors.
The associations between microbes and both immune system modalities were
assessed with two linear models, adjusted for age and sex, testing for effects on trained
immunity and specific T cell responses (“Methods”). Trained immunity was associated
with 40 significant species (prevalence > 20%, FDR < 0.2, Fig. 2D; Additional file 3:
Table S2), while specific immunity was associated with three species: Ruminococcus
(MSP 091), Eggerthella lenta (MSP 181), and Streptococcus thermophilus (MSP 076)
(Fig. 2E; Additional file 3: Table S2). At FDR < 0.1, 27 species were associated with
trained immunity. Because the model for the trained immunity response combined
more biological markers (three cytokines) than that for the specific response (one cyto-
kine), it retrieved more species at the same significance threshold. Nevertheless, both
modalities elicited a non-uniform distribution of p-values (Fig. 2F), supporting an influ-
ence of the microbiome on BCG vaccine responses.
We next examined the correlation between species relative abundance and individual
cytokine production at both time points after vaccination (Fig. 2G). A Roseburia gen-
ome (MSP 112), only identifiable on the genus level, was negatively correlated with the
increase in IL-1ß and TNF-α production at both time points (P = 2.67e−05, FDR =
0.0011, Fig. 2H). In the specific response model, Ruminococcus (MSP 091, P = 0.0012,
FDR = 0.17) and E. lenta (MSP 181, P = 0.0030, FDR = 0.17) showed consistent negative
and positive effects, respectively, on IFN-γ at both time points (Fig. 2I). The specific re-
sponse model revealed the most associations between a single cytokine and microbial spe-
cies, although for all the cytokine–stimuli combinations, the number of unadjusted
associations ranged between 10 and 23 microbes (Additional file 4: Table S3).
Immunomodulatory microbes strongly influence circulating metabolites
Detectable changes in cytokine production yielded potential immunomodulatory spe-
cies, whose exact numbers varied with selected statistical thresholds. To corroborate
cytokine associations and narrow down the potential causal mechanisms, we compared
the effects of immunomodulatory microbes on the plasma metabolome, measured as
previously described [59]. A total of 1607 mass/charge (m/z) peaks were matched to
known compound identities and clustered into 20 groups, enriched for eight major mo-
lecular classes (Additional file 1: Fig. S4A-C, “Methods”).
Canonical correlation analysis confirmed a strong microbiome effect on compound
intensities, as 15 of the top 25 canonical components (CCs) showed significant ex-
plained variance (Additional file 1: Fig. S4D-E). A t-SNE projection of the top 25 CCs
showed strong grouping by molecular class, with evident co-occurrence of microbes in
clusters harboring carboxylic acids and derivatives, glycerophospholipids and organic
sulfuric acids (Fig. 3A). The three immunomodulatory species Roseburia (MSP 112),


















































































(2) MSP 006 Bacteroides vulgatus 
(1) MSP 007 Bacteroides vulgatus 
(1) MSP 024 Bacteroides caccae 
(3) MSP 030 Coprococcus 
(2) MSP 029 Subdoligranulum variabile 
(3) MSP 071 Blautia sp. KLE 1732 
(1) MSP 143 Blautia obeum 
(1) MSP 076 Streptococcus thermophilus 
(1) MSP 201 Phascolarctobacterium 
(1) MSP 297 Dorea formicigenerans 
(2) MSP 036 Eubacterium siraeum 
(1) MSP 054 Parabacteroides merdae 
(1) MSP 182 Eubacterium 
(2) MSP 032 Roseburia sp. 831b 
(1) MSP 149 Faecalibacterium 
(1) MSP 090 Holdemanella biformis 
(1) MSP 224 Lachnospira 
(1) MSP 293 Blautia wexlerae 
(3) MSP 181 Eggerthella lenta 
(2) MSP 163 Lachnospiraceae bacterium TF01 11 
(2) MSP 091 Ruminococcus 
(4) MSP 112 Roseburia 
(2) MSP 166 Clostridiales bacterium KLE1615 
(2) MSP 062 Dorea sp. Marseille P4042 
(1) MSP 203 Blautia sp. SG 772 
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Fig. 2 Microbial species abundance changes with differences in trained and stimulus-specific immune responses. A
Ex vivo cytokine expression upon stimulation with M. tuberculosis (M. tb) or S. aureus at baseline (b) and at 2 weeks
(2w) and 3 months (3m) after BCG vaccination. P-values were determined by paired Kruskal-Wallis tests. Significant
correlations between changes in cytokine expression at 2 weeks (B) and 3 months (C), measured as fold change
against baseline levels (Spearman correlation, P < 0.05). Diagonal cells show significance of changes for each individual
cytokine versus baseline (T-test, *P < 0.05, ***P < 0.001). D Significant MSPs associated with trained immune responses
subject to FDR < 0.2 and prevalence > 20%. The effect of each MSP was estimated by a linear model of the fold
change in TNF-α, IL-1β, and IL-6 responses versus the baseline, adjusted for age and sex (“Methods”). E Significant
MSPs associated with specific response (IFN-γ stimulated by M. tuberculosis) and subject to FDR < 0.2 and prevalence
> 20%, using a model of the same form as in D. F Distribution of unadjusted P-values for each MSP in the trained and
specific response models. Skew from uniform distribution suggests more pronounced effects of MSPs on cytokine
expression fold change. G Individual effects on cytokine fold changes by each MSP and time point, quantified as
explained variance multiplied by effect sign. Number of associations per MSP and confidence in species-level
annotation are reported on the left. HMSP 112 (Roseburia) abundance decreases two of the three trained immunity
phenotypes in both subsequent time points. Relative abundance of the MSP was converted to ranks, and ranks were
sorted into bins by equal-frequency binning. P-values in titles refer to the trained immunity linear model. Coefficients
in panels are Spearman correlations (*P < 0.1, ***P < 0.001). I MSP 091 (Ruminococcus) and MSP 181 (Eggerthella lenta)
ranked abundance versus specific response phenotype. Relative abundance of the MSP was converted to ranks, and
ranks were sorted into bins by equal-frequency binning. P-values in titles refer to the specific response linear model.
Coefficients in panels are Spearman correlations (*P < 0.1, **P < 0.01)
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Ruminococcus (MSP 091), and E. lenta (MSP 181) strongly influenced the composition
of the metabolite space, as seen by their polarized placement in the joint projection
(Fig. 3A).
Fig. 3 Immunomodulatory species strongly influence the serum metabolome. A Canonical correlation
analysis (CCA) between abundances of the 345 MSPs and 1607 annotated metabolites across all 321
samples. Twenty-five canonical components with significant increase in explained variance were projected
in two dimensions using t-SNE. Positions of three immunomodulatory MSPs (left) and metabolite classes
(right) are highlighted. Joint deviation of points from the origin (coordinate 0, 0) reflects increased
covariance and grouping between metabolites and MSPs. B MSPs showing effects on cytokine responses
have larger effects on metabolite intensities. Distribution of maximum absolute Spearman correlations per
MSP across all metabolites. MSPs present in at least 20% of the samples and significant subject to P < 0.05
(left), < 0.1 (center), and < 0.2 (right) in any of the two log-linear models are shown in blue and the
remaining non-significant MSPs are in white. Dotted vertical line shows threshold for significantly correlated
species and metabolites (PBonferroni < 0.05). C All 32 significantly associated metabolites by 34 MSPs. Colored
heat map cells show Spearman correlations with PBonferroni < 0.05. Columns (MSPs) are sorted by minimum
P-value from any of the two log-linear models. Asterisks indicate MSPs associated in cytokine responses
shown in Fig. 2
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Next, we investigated whether immunomodulatory microbes have stronger effects on
individual metabolites compared to the other microbes. All pairwise Spearman correla-
tions yielded 198 significant associations (PBonferroni < 0.05) between 34 MSPs and 32 me-
tabolite intensities (Additional file 5: Table S4). While most associations were positive
(183/198), the resulting increase in metabolite intensities might result both from microbe-
mediated anabolism or compound breakdown. To test whether species with large effects
in either of the two linear models are more likely to elicit significant effects on the metab-
olome, we used three different thresholds that selected at least 40 species and computed
the largest absolute effect on any one metabolite. All three settings yielded an enrichment
of significant effects among immunomodulatory microbial species (maximum P < 10−11,
Chi-square test, Fig. 3B). This confirmed that microbial species with effects on cytokine
production also have strong effects on circulating metabolites.
Of the 198 significant metabolite associations, 18 were associated with the presence
of Roseburia (MSP 112), the most of any MSP, and one with E. lenta (MSP 181) (Fig.
3C). Due to uncertainty in annotation and pathway-mediated dependence on metabol-
ite abundance, we attempted to identify general mechanisms by grouping the metabo-
lites using KEGG pathways. Phenylalanine metabolism was influenced most strongly by
Roseburia (MSP 112), with four metabolite associations in this pathway. Roseburia
(MSP 112) additionally influenced three metabolites each in tryptophan metabolism
and biosynthesis of secondary metabolites (Fig. 3C).
Untargeted plasma metabolomics detected two SCFAs, acetate and propionate, which
are microbial products of dietary fiber metabolism and candidate mediators of host–
microbiome signaling [14]. Both molecules showed significant positive associations with
trained immunity but not with the specific response (Additional file 1: Fig. S5). While
immunomodulatory microbes were not significantly correlated with either acetate or
propionate, E. lenta had the highest positive correlation with propionate.
Butyrate, an SCFA previously shown to decrease IL-6 production [22], was not detected in
circulation, possibly due to its absorption in the gut [23]. Nevertheless, butyrate kinase, which
catalyzes the last step of butyrate biosynthesis [24], was detected in a single Roseburia (MSP
209) and five Coprococcus species, where Coprococcus (MSP 030) had the strongest positive
association with trained immunity, in particular an increase in IL-6, after vaccination (Add-
itional file 1: Fig. S6A-C). Conversely, Coprococcus comes (MSP 213) correlated with a de-
creased trained immunity response, manifested in reduced TNF-α expression after 3 months
(Additional file 1: Fig. S6D). The absence of butyrate kinase in immunomodulatory Roseburia
(MSP 112) may stem from gaps in assembled genomes or allow for metabolic modalities other
than SCFAs in mediating BCG-induced immunity.
Combined evidence from the (i) modeled effects of microbes on cytokine production,
(ii) associations between species relative abundances and the production of two trained
immunity-related cytokines at both time points after vaccination, and (iii) effects of the
immunomodulatory microbiome species on the plasma metabolome yielded the predic-
tion that Roseburia-mediated phenylalanine metabolism influences trained immunity.
Roseburia encodes phenylalanine pathway enzymes that are prevalent and abundant
The effects on phenylalanine metabolites prompted us to investigate the Roseburia ge-
nomes and confirm the presence of relevant enzymes. We compared the differential
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enzymatic and metabolic potential of Roseburia to phylogenetically and biochemically
related taxa by a deeper profiling of the stool metagenomes. All 345 identified MSPs
were grouped by phylogenetic divergence using core genes (PhyloPhlAn 3.0, Additional
file 1: Fig. S7), revealing a clade harboring most Roseburia species (Fig. 4A). The phylo-
genetically closest Firmicutes included five Ruminococcus, three Coprococcus and two
Eubacterium rectale MSPs. While E. rectale is related to Roseburia in terms of butyrate
production, we also included a biochemically distinct but abundant Actinobacteria Bifi-
dobacterium (MSP 111). The assembled panel consisted of 59 MSPs derived from
85,208 assembled genes of Bifidobacterium (7 MSPs), Roseburia (13 MSPs), Ruminococ-
cus (17 MSPs), Eubacterium (15 MSPs), and Coprococcus (7 MSPs), with each genus
having more than 95% prevalence in the cohort (Fig. 4B).
A total of 330 genes mapped to 20 out of 77 enzymes in the phenylalanine pathway
(KEGG ko00360). Roseburia contributed the most genes (92, 45.1% average prevalence;
Fig. 4C; Additional file 6: Table S5), whereas other genera in the panel contributed
fewer [Ruminococcus (77, 19.2%), Eubacterium (66, 36.3%), Coprococcus (50, 35.5%) and
Bifidobacterium (45, 46.1%)]. Roseburia also encoded the most phenylalanine enzymes
(13 out of 20). Of these, hisC, mhpE, yhDR, paaH, paaF, paaI, and enr were signifi-
cantly more abundant in Roseburia than in all of the other four genera (Fig. 4D).
A total of 15 m/z peaks matched to compounds from the phenylalanine pathway
(KEGG ko00360), potentially spanning up to 19 compounds due to ambiguous
matches. Species from the Roseburia genus significantly correlated with 11 of the 15
compounds in the pathway, of which MSP 112 contributed to six of these compounds
(Spearman correlation, P < 0.05, Fig. 4E). The genera Ruminococcus, Coprococcus, Bifi-
dobacterium, and Eubacterium each showed fewer associations (Fig. 4E). Taken to-
gether, Roseburia’s increased influence on the phenylalanine metabolism pathway
compared to closely related species is confirmed through increased enzymatic potential
and metabolite intensity.
Comparison of Roseburia genomes reveals alternate routes in phenylalanine metabolism
Finally, we more closely investigated the 13 phenylalanine metabolism enzymes found
within the Roseburia genus and their differential effects on circulating metabolites. Five
of the enzymes (hisC, mhpE, paaH, yhDR, and paaF) were common to over half of the
MSPs, while the remaining eight were more species-specific (Fig. 5A). The co-
occurrence of aaaT (L-phenylalanine N-acetyltransferase) and paaI (acyl-CoA thioes-
terase) was specific to the immunomodulatory MSP 112, as they were not found to-
gether in any other Roseburia MSP. These enzymes act in the path from phenylalanine
to N-acetyl-L-phenylalanine and phenylacetylglutamine, whose plasma concentrations
were associated with increased Roseburia (MSP 112) abundance (Fig. 4E).
Correlations between individual enzyme abundances and compound intensities re-
vealed two distinct pathway modalities. First, an increase in L-tyrosine, L-
phenylalanine, and phenylpyruvate (m/z ambiguous matches: 2−hydroxy−3−phenylpro-
penoate, trans−3−hydroxycinnamate) was accompanied by the five commonly shared
enzymes (hisC, mhpE, paaH, yhDR, and paaF) as well as hipO (grouped by blue bars in
Fig. 5B). Second, HPD, paaK, aaaT, and padE were associated with an increase in phe-
nylpropanoate, hippurate (m/z ambiguous match: phenylacetylglycine), and
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phenylacetylglutamine (grouped by orange bars in Fig. 5B). The latter compounds also
strongly decreased with the presence of the five shared enzymes, suggesting an oppos-
ing mechanism between the two groups of compounds and enzymes.
We assessed the significance of the observed correlations to verify that the differences
in compound intensities in each group were indeed more likely due to the associated
enzymes than any other genes. The Spearman correlation between sums of enzyme
abundances and compound intensities within each group revealed even stronger effects
than any individual compound–enzyme association (Fig. 5C, top-left and bottom-right
panels). Conversely, correlations between groups showed weak to negative effects (Fig.
5C, top-right and bottom-left panels). Finally, the observed correlations were compared
to a null distribution of correlations from 10,000 random draws of six (blue group) or
Fig. 4 Phenylalanine pathway enzymes encoded by Roseburia are prevalent and abundant. A A subtree of
the phylogenetic relationships among detected MSPs, containing the majority of MSPs mapped to the
Roseburia genus (PhyloPhlAn 3.0). B Total abundance of each genus in the cohort. C Assembled genes
encoding 20 of the 77 enzymes in the phenylalanine metabolism pathway (KEGG ortholog ko00360) across
samples, sorted by MSPs in each genus. Heatmap shows samples where a gene is detected. D Total
abundance of individual genes in the phenylalanine metabolism pathway. For each KEGG ortholog group,
statistics of all assembled homologs were aggregated. Each enzyme encoded by Roseburia was tested for
increased abundance (read per million mapped reads, RPKM) compared to the other four genera in the
panel. The minimal P-value from up to four comparisons is shown for the cases where Roseburia has the
highest abundance. Black points show the median, and the error bars mark the 25th and 75th percentiles. E
Spearman correlations of MSPs in the panel with 16 detected metabolite features (mass-to-charge, m/z,
peaks in mass spectra) mapping to the phenylalanine metabolism pathway. Only the top matching
compound name is shown, while ambiguous matches are shown on the right. For each genus, the
strongest effect associated with any relevant MSP was chosen and marked as significant subject to P < 0.05.
The effects associated with MSP 112 (Roseburia) are highlighted in the black box
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four (orange group) genes from all 22,832 Roseburia genes. Indeed, all four observed ef-
fects were extreme when compared to random sets of genes (Fig. 5D), confirming that
the opposing compound–enzyme associations are unlikely to be due to other Roseburia
genes. The complete sets of detected compounds and enzymes are shown in Fig. 5E,
with group separation indicated. These results reveal two mechanisms, each character-
ized by a mutually exclusive set of enzymes and compounds, outlining how species-
level differences in Roseburia may affect phenylalanine metabolites in circulation.
Additional evidence for the capability of Roseburia to alter compounds in the phenyl-
alanine metabolism pathway is provided by a study that performed targeted metabolo-
mics using reference standards on supernatants of individual microbial species grown
Fig. 5 Integrative analysis of Roseburia effects on the phenylalanine metabolism pathway (KEGG ko00360).
A Total abundances of enzymes encoded by MSPs in the Roseburia genus, with MSP 112 highlighted in the
black box. B Observed enzymes and compounds in the phenylalanine pathways. Compounds and enzymes
in blue and orange groups are colored accordingly. Significant Spearman correlations between enzymes
encoded by Roseburia and phenylalanine metabolism compound intensities. Only the top matching
compound name is shown. Compound enzyme groups are indicated by orange and blue bars. The black
line emphasizes the separation between the two groups. C Correlation between total abundances of
enzymes and average intensities of compounds grouped by blue and orange bars in B. D Null distribution
of correlations between selected compounds and random groups of six (blue group) or five genes (orange
group) from the Roseburia genomes. Observed Spearman correlations (as in C) are marked with a black
vertical line and the null distribution is shown in gray. E Phenylalanine metabolism pathway (KEGG
ko00360). Detected compounds and enzymes are colored in blue and orange
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in defined media [25], including Roseburia inulinivorans, a close relative of Roseburia
(MSP 112) with species-level annotation (Fig. 4A). A change of at least twofold in R.
inulinivorans supernatant was observed for two compounds: an increase in 2-
hydroxyacetate, which is encoded downstream of yhDR and hisC, and a decrease in
succinate, which is encoded upstream of mphE (Additional file 1: Fig. S8, Fig. 5D). Al-
though these compounds were not detected using our plasma metabolomics methods,
the direction of changes is aligned with the relevant genes and supports an active role
of Roseburia in phenylalanine metabolism pathways.
Discussion
Growing evidence suggests that the gut microbiome mediates effects on vaccine effi-
cacy through microbial ligands, circulating metabolites or both. Here, we identified mi-
crobial species associated with BCG-induced specific (adaptive immune memory) and
heterologous (trained immunity) responses. De novo assembly methods and associa-
tions with circulating metabolites and cytokines at multiple time points enabled us to
obtain statistically robust microbial signals that would otherwise be missed by
reference-based methods.
We uncovered a total of 43 immunomodulatory microbes, including two species that
showed consistent effects through metagenomic and metabolomic analyses: Roseburia
(MSP 112) negatively associated with cytokine responses upon BCG-induced nonspe-
cific immunity, while Eggerthella lenta positively associated with BCG-induced specific
T cell-mediated memory responses. To date, the only other study investigating the
BCG vaccination and human gut microbiota was performed with a cohort of 48 infants
from Bangladesh [20]. Positive associations were observed between Actinobacteria (in-
cluding Bifidobacterium) and immune responses, as measured by T cell proliferation
and delayed-type hypersensitivity skin test, 15 weeks after BCG vaccination at birth. Al-
though it is difficult to extrapolate these results to our cohort, we also observed that a
genus of Actinobacteria (Eggerthella) was associated with specific T cell immune re-
sponses upon BCG vaccination.
Microbial products and cell wall components such as low-dose lipopolysaccharides
(LPS) are known to modulate immune response and tolerance through engagement of
host pattern recognition receptors [26]. Trained immunity responses in particular were
shown to be dependent on engagement of the NOD2 receptor by muramyl dipeptide
(MDP), the active component of mycobacterial peptidoglycans [27], which positively
correlated with changes in IL-6, IL-1β, and TNF-α upon S. aureus stimulation 3
months after BCG vaccination [28]. As MDP can originate from the microbiome [29],
it is unsurprising to detect numerous microbial associations with BCG-induced trained
immunity (Fig. 2D, E).
Roseburia species produce SCFAs such as butyrate, which are known to possess im-
munomodulatory properties [30]. Interestingly, butyrate supplementation reduces in-
duction of trained immunity [31], which could be speculated to be an additional
mechanism through which Roseburia modulates trained immunity. Associations be-
tween Roseburia and atherosclerosis [32] — a process in which trained immunity also
plays an important role [33] — as well as between Eggerthella and rheumatoid arthritis
[34], multiple sclerosis [35], and inflammatory bowel disease [36] further suggest im-
munomodulatory roles for these species. Moreover, E. lenta is often associated with
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serious gastrointestinal infections [37] and has been shown to increase intestinal T
helper 17 cell numbers and worsen murine models of colitis.
Upon analyzing microbiome composition in conjunction with health-related variables
from a questionnaire, we identified correlations between variations in the intestinal
microbiome and adult vaccinations against influenza, yellow fever, and HPV. However,
we are unable to determine whether these vaccinations altered microbiome compos-
ition or whether different lifestyles associated with additional vaccinations contributed
to differences in the microbiome. In line with this, changes in the microbiome associ-
ated with yellow fever and influenza vaccination also coincided with participants travel-
ing outside Europe. Variables including history of vaginal fungal infections, sex, diet,
diarrhea, antibiotic use, and daily exercise also correlated with the number of changes
in species relative abundance. The latter five factors are known to impact the gut
microbiome [38–42]. Interestingly, hay fever during youth was associated with Verruco-
microbia, which has been observed at higher abundance in infants with allergy [43].
While gut microbiome profiles correlated with a number of health-related variables,
overall metabolic health (e.g., BMI) did not correlate with cytokine responses upon
stimulation, likely since our cohort is composed of healthy young adults (median age
23 and BMI = 25 at the 85th percentile).
The immunomodulatory microbes we identified, in particular Roseburia (MSP 112),
had a stronger impact on circulating metabolites than the other microorganisms, sug-
gesting a mechanism through which immune responses are influenced. Of the metabo-
lites associated with metagenomic species, several were already known to be produced
or modified by the gut microbiome, including acetyl-N-formyl-5-methoxykynurena-
mine (AFMK) [44], p-cresol sulfate [45], 5-hydroxytryptophol [46], hydrocinnamic acid
[47], 4-ethylphenyl sulfate [48], hippurate [49], mandelonitrile [50], and 3-methylindole
[51].
Most of the metabolites corresponding with microbiome changes were related to
phenylalanine, an essential amino acid involved in many processes and that is also con-
verted into tyrosine. Tyrosine comprises catecholamines and is involved in fumarate
production, both of which are known to induce trained immunity responses [52].
Phenylalanine to tyrosine synthesis is facilitated by cofactor BH4, whose availability is
influenced by pro- and anti-inflammatory stimuli in human macrophages. In general,
increased serum phenylalanine concentrations are found during immune activation in
humans, most likely due to the reduced converting rate. In phenylketonuria, a human
congenital disorder in which a mutation in phenylalanine hydroxylase leads to high
phenylalanine concentrations, a deficit of tyrosine and catecholamines is observed [53].
Microbial derivatives of phenylalanine and tyrosine, including microbiota-dependent
metabolites p-cresol sulfate and phenylacetylglutamine [54], are known to contribute to
chronic kidney disease pathogenesis and disease progression by inducing renal damage
and inflammation [55, 56]. Furthermore, these metabolites have been associated with
overall mortality and cardiovascular disease in individuals with kidney disease [54], and
phenylacetylglutamine is a risk factor for major adverse cardiovascular events [57].
The Roseburia genus was associated with 11 out of 15 compounds in the phenylalan-
ine pathway, with MSP 112 having the strongest effect. Moreover, the Roseburia genus
encodes enzymes in the phenylalanine metabolism pathway itself. Related Firmicutes
Ruminococcus, Eubacterium and Coprococcus, as well as Bifidobacterium displayed
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decreased enzyme presence compared to Roseburia. The enzymes detected in MSP 112
and absent in the majority of other Roseburia genomes were L-phenylalanine N-
acetyltransferase (aaaT), acyl-CoA thioesterase (paaI), and 4-hydroxy 2-oxovalerate al-
dolase (mhpE), which are found at different steps in the phenylalanine pathway. Not-
ably, mhpE is involved in the production of pyruvate [58], and although pyruvate was
not associated with Roseburia itself, it is used during trained immunity to increase
metabolic activity [21].
Limited sensitivity and coverage of current metagenomic methods do not exclude the
existence of additional, undetected immunomodulatory microbes. Nevertheless, associ-
ations with cytokine expression, circulating metabolites, and differential presence of
phenylalanine metabolism enzymes increase the confidence that the presence of Rose-
buria in the gut microbiome dampens trained immune responses after BCG vaccin-
ation. Further investigation of the role of phenylalanine metabolism in these responses
is warranted in future studies, as a possible causal role between Roseburia species and
phenylalanine metabolism is supported by recently published in vitro experiments and
should continue to be investigated in similar controlled settings. Furthermore, since in-
dividuals included in this study were all from Western European ancestry, of adult age,
and living in similar environments, these findings should be validated in additional co-
horts of different age groups and of different genetic backgrounds. This study neverthe-
less provides a detailed insight into associations between assembled microbial genomes,
plasma metabolites and subject-specific immune responses.
Conclusions
The data presented here details for the first time microbiome-associated effects on
BCG vaccine responsiveness in a large human cohort. The pathways and microbial spe-
cies that mediate BCG-induced trained and specific immune responses contribute to
the understanding of subject-specific immunity and may inform personalized strategies
to enhance vaccine efficacy.
Methods
Experimental model and subject details
In the 300BCG study, 321 healthy Dutch individuals were included from April 2017
until June 2018. Individuals were not included if they did not have a Western European
ancestry, used systemic medication other than oral contraceptives and acetaminophen,
used antibiotics 3 months before inclusion, received previous BCG vaccination, had a
history of tuberculosis, any febrile illness 4 weeks before participation, vaccination 3
months before participation, or a medical history of immunodeficiency. Individuals
were excluded for not meeting inclusion criteria (n = 2), medication use (n = 4), differ-
ent time of vaccination (n = 18), or a missing stool sample (n = 1). At the hospital,
written informed consent was obtained, stool and blood samples were collected, and
participants were vaccinated with a standard dose of 0.1 mL BCG Bulgaria (InterVax)
intradermally in the left upper arm. At 2 weeks and 3 months after vaccination, blood
was again collected and a questionnaire was completed. This study was approved by
the Arnhem-Nijmegen Medical Ethical Committee (NL58553.091.16) and performed in
accordance with the Declaration of Helsinki.
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Method details
PBMC isolation and stimulation
Ficoll-Paque (GE Healthcare, UK) density gradient separation was used to isolate per-
ipheral blood mononuclear cells (PBMCs) from EDTA whole blood. After washing
twice with phosphate buffered saline (PBS), cells were counted with the Sysmex
hematology analyzer (XN-450) and resuspended in culture medium consisting of Dutch
modified RPMI 1640 (Invitrogen, USA) supplemented with 50 μg/mL gentamicin, 2
mM Glutamax (Gibco Life Technologies), and 1 mM pyruvate (Gibco Life Technolo-
gies). Five hundred thousand PBMCs per well were added to a round bottom 96-well
plate (Greiner) and stimulated with culture medium (control), heat-killed Mycobacter-
ium tuberculosis HR37v (5 μg/mL), or heat-killed Staphylococcus aureus (106 CFU/mL,
clinical isolate), and incubated at 37 °C, 5% CO2, for 24 h or 7 days. Medium of 7 days
stimulation was supplemented with 10% human pooled serum. After 24 h and 7 days,
supernatants were collected and stored at −20 °C until further analysis.
Cytokine measurements
IL-1β, IL-6, and TNF-α (R&D Systems) concentrations were measured in 24-h superna-
tants with ELISA, according to the manufacturer’s protocol. IFN-γ was measured in 7-
day supernatants with Luminex (ProcartaPlex, Thermo Fisher), according to the manu-
facturer’s protocol. The cytokine concentrations were measured in pg/mL, adjusted for
plate variation using linear model residuals, and log-transformed.
Untargeted plasma metabolomics
Plasma was obtained from participants by centrifugation of EDTA blood and was im-
mediately stored at −80°C until further analysis. Flow injection-time-of-flight mass
(flow injection TOF-M) spectrometry was performed by General Metabolomics (Bos-
ton, USA), as previously described [59]. A list of putative metabolites was annotated
with a series of analysis strategies including deisotoping, decluttering, adduct detection,
and library matching in KEGG, HMDB and CHEBI databases, resulting in 1,607 anno-
tated features. All metabolomic measurements were performed in duplicate, and the
average value was calculated for each sample per feature.
Stool samples collection and sequencing
Stool samples were collected at home the day before or on the day of blood collection,
time was recorded, and samples were stored in the refrigerator at home. At the hospital
visit before BCG vaccination, samples were immediately aliquoted and stored at −80 °C.
Nucleic acids were extracted the AllPrep 96 PowerFecal DNA/RNA kit from QIAG
EN (custom product # 1114341). This method pairs bead-beating on a Tissuelyser II
(QIAGEN) with a 96-well AllPrep protocol and is available through QIAGEN. Bead-
beating is performed twice at 20 Hz for 5 minutes each round with a rotation of the
plate in between rounds. Purified DNA was stored at –20 °C. Metagenomic sequencing
libraries were prepared from 2 ng of input DNA using the Nextera XT DNA Library
Preparation kit (Illumina) according to the manufacturer’s recommended protocol.
Prior to sequencing, libraries were pooled by collecting equal volumes of each library.
Insert sizes and concentrations for each pooled library were determined using an
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Agilent Bioanalyzer DNA 1000 kit (Agilent Technologies) prior to sequencing on an
Illumina NovaSeq 6000 with 151 bp paired-end reads to yield ~ 10 million paired-end
reads per sample. Data was analyzed using the Broad Picard Pipeline which includes
de-multiplexing and data aggregation (https://broadinstitute.github.io/picard).
Quantification and statistical analysis
Metagenomics data processing
The quality control for sequencing data was conducted using Trim Galore! to detect
and remove sequencing adapters (minimum overlap of 5 bp) and kneadData to remove
human DNA contamination and trim low-quality sequences (HEADCROP:15 SLI-
DINGWINDOW:1:20), retaining reads that were at least 50 bp. Metagenomic reads
from all cohorts were assembled individually for each sample into contigs using Mega-
HIT [60], followed by an open reading frame prediction with Prodigal [61] and retain-
ing only full length genes (containing both start and stop codon).
A non-redundant gene catalog was constructed by clustering predicted genes based
on sequence similarity at 95% identity and 90% coverage of the shorter sequence using
CD-HIT [62]. Reads were mapped to the gene catalog with BWA [63], filtered to in-
clude strong mappings with at least 95% sequence identity over the length of the read,
counted (count matrix) and normalized to transcript-per-million (TPM matrix). Count
matrix served as an input for binning genes into metagenomic species pan genomes
(core and accessory genes) using MSPminer with default settings [64].
The abundance of an MSP was quantified as median gene TPM. The genes forming
each MSP were quantified as reads per kilobase (RPK).
We annotated the gene catalog at species, genus, and phylum levels with NCBI
RefSeq (version May 2018) as described previously [65]. The KEGG Orthogroups were
assigned to each gene in the catalog using eggNOG-Mapper [66].
The PhyloPhlAn 3.0 with default settings [67] was used to organize the phylogenetic
tree of MSPs based on similarity in core genes.
For comparison with the 500FG cohort, we used the sample pipeline as described in
the associated publication [12]. After the kneadData quality control step, marker-gene
based taxonomic annotation tool MetaPhlAn [68] yielded relative abundances of 202
species, of which 199 were shared between the two cohorts.
Clustering of metagenomic species
The abundances of MSPs were normalized to relative abundance in each sample. The
clusters were determined based on the Jensen-Shannon divergence and a consensus
hierarchical clustering with pvclust using 100 bootstrap runs. The number of clusters
was determined to maximize the difference of average between- and within-cluster
divergences.
Variable associations with metagenomic species
We tested variables known for at least 200 samples and had a minimum 40 samples
per categorical variable level. Maaslin2 generalized linear model was used to model dif-
ferential abundance of each MSP and the recommended threshold of PFDR < 0.25 was
applied.
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Significance of cytokine expression changes after vaccination
Significance of increased log cytokine expression over three time points was assessed
using paired Kruskal-Wallis test. The T-test was used to determine significance of fold
changes from the baseline time point for 2 weeks and 3 months. Spearman correlation
was used to test for significant correlations between cytokine levels.
Associations between metagenomic species and changes in cytokine expressions
To find potential immunomodulatory species affecting the magnitude in the immune
response after BCG vaccination, we combined the data on cytokine expression over
three time points with stool samples at baseline and subjects’ age and sex. We included
303 samples vaccinated in the morning and at least two cytokine measurements (i =
1...303) and 163 metagenomic species (MSPs) with at least 20% prevalence (m =
1...202). Cytokine expressions (c) were quantified as fold change against the baseline for
measurements after 2 weeks and 3 months (t = 2 weeks, 3 months). To equalize the
variance in cytokine expressions, the fold changes were standardized for each cytokine
and time point using the z-score transform.
Trained and specific responses were assessed with two separate models. The cyto-
kines TNF-α, IL-1β and IL-6 stimulated with S. aureus were used to quantify the
trained immune response, while IFN-γ stimulated with M. tuberculosis was used to de-
tect the specific immune response. Excluding missing values, the trained immunity
model comprised 1685 observations, while the specific response model comprised 535
observations. For both response types the z-scored fold changes zc,t,i were fit using the
linear model
zc;t;i ¼ α0 þ αaagei þ αssexi þ αmmspm;i þ εc;t;i;
with the following parameters: εc,t,i is the unexplained variance, α0 the intercept, and
αa, αs, αm coefficients for age, sex, and MSP abundance, respectively. The subject-
specific variables are agei (continuous), sexi (discrete), and mspm,i the relative of the
MSP m, converted to ranks (where no abundance amounts to rank 0 and maximum
abundance to rank 302). Note that there is no separate longitudinal or cytokine coeffi-
cient, as we sought species that associate with responses in all cytokines at both time
points, effectively treating the measurements as replicates in order to decrease model
complexity and increase statistical power. Despite the observations not being entirely
independent (each subject can be repeated in multiple time points and cytokines), we
chose to treat them as such rather than average across cytokines and timepoints, treat-
ing them as separate experiments that bear additional information.
To account for co-abundance effects, each of the two models was fit once for each
MSP, using the R function lm. The MSPs were deemed immunomodulatory if αm had a
significant contribution after multiple testing adjustment (PFDR < 0.2, T-test). The ex-
plained variance in cytokine expression fold change was computed for each MSP, using
the model based on age and sex alone:
zc;t;i ¼ β0 þ βaagei þ βssexi þ γc;t;i;
where β0, βa, and βs are the ordinary least squares coefficients and the explained vari-
ance is estimated as squared Pearson correlation between ranked MSP abundance and
residuals γc,t,i. Note that this estimate is conservative in the context of a single isolated
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MSP, as the effect of age and sex is explained away using their full least squared
coefficients.
Metabolomics statistical analysis
Metabolite intensity was standardized (z-scored) across samples. Clusters were obtained
using k-means, with the number of clusters determined by optimal matching to the
molecular classes (from HMDB database) using adjusted random index (ARI) measure.
The two dimensional projection was obtained using t-SNE.
Canonical correlation analysis (CCA) between standardized metabolite intensity
matrix M (321 samples times 1607 metabolite features) and MSP abundance matrix S
(321 samples times 345 MSPs) was performed by singular value decomposition of the
covariance matrix
UDVT ¼ MTS;
where U and V are orthonormal matrices of canonical vectors and D is the diagonal
matrix of explained variances. The significance of canonical vectors was assessed by
comparing diagonal entries in D against the null distribution, simulated by 1000 ran-
dom permutations of M and S and subject to threshold P < 0.05. The top 25 canonical
vectors in U, V were then projected to two dimensions using t-SNE.
Metabolite intensities were compared to relative species abundance and cytokine ex-
pressions using Spearman correlation subject to PBonferroni < 0.05.
To compare intensity of multiple metabolites with abundance of multiple enzymes,
the respective intensities and abundances were averaged and Spearman correlation was
calculated.
Associations between pathways, genes, and compounds
The KEGG pathways KGML data formats were used to link metabolite and enzyme
identifiers with metabolic pathways. The enzyme and pathway identifiers used the
KEGG ortholog (ko) format. The metabolite features mapped to 721 KEGG compound
identifiers, contained in 350 metabolic pathways. Out of 10,049 enzymes associated
with the 350 pathways, 2726 were detected in the stool metagenomes.
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